The Humira Biosimilar Market is estimated to be valued at US$ 772.1 million in 2023 and is expected to exhibit a CAGR of 25.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:
The Humira Biosimilar market refers to the market for generic versions of Humira, a widely used medication for treating autoimmune diseases such as...
0 Commentarios
0 Acciones
1407 Views
0 Vista previa